Key result
Minimal access AVR linked to ~40% lower 30-day mortality versus standard sternotomy.
Why the study?
Despite long-term experience, minimal access surgical aortic valve replacement (mini-AVR) is not routinely adopted compared to conventional full sternotomy.
Does a minimal access approach reduce 30-day mortality compared to full sternotomy in patients undergoing surgical aortic valve replacement?
Cohort (n=5,801)
Yes
Does a minimal access approach reduce 30-day mortality compared to full sternotomy in patients undergoing surgical aortic valve replacement?
Minimal access surgical aortic valve replacement may reduce 30-day mortality and length of stay compared to full sternotomy, though it is associated with longer procedural times and higher rates of transfusion and atrial fibrillation.
Answers are grounded in this paper and cite their sources.
May support minimal-access AVR in selected patients; leaves open randomized confirmation of mortality benefit.
OBJECTIVES: Surgical aortic valve replacement (AVR) can be performed via a full sternotomy or a minimal access approach (mini-AVR). Despite long-term experience with the procedure, mini-AVR is not routinely adopted. Our goal was to compare contemporary outcomes of mini-AVR and conventional AVR in a large multi-institutional national cohort. METHODS: A total of 5801 patients from 10 different centres who had a mini-AVR (2851) or AVR (2950) from 2011 to 2017 were evaluated retrospectively. Standard aortic prostheses were used in all cases. The use of the minimally invasive approach has increased over the years. The primary outcome is the incidence of 30-day deaths following mini-AVR and AVR. Secondary outcomes are the occurrence of major complications following both procedures. Propensity-matched comparisons were performed based on the multivariable logistic regression model. RESULTS: In the overall population patients who had AVR had an increased surgical risk based on the EuroSCORE, and the 30-day mortality rate was higher (1.5% and 2.3% in mini-AVR and AVR, respectively; P = 0.048). Propensity scores identified 2257 patients per group with similar baseline profiles. In the matched groups, patients who had mini-AVR, despite longer cardiopulmonary bypass (81 ± 32 vs 76 ± 28 min; P = 0.004) and cross-clamp (64 ± 24 vs 59 ± 21 min; P ≤ 0.001) times, had lower 30-day mortality rates (1.2% vs 2.0%; P = 0.036), reduced low cardiac output (0.8% vs 1.4%; P = 0.046) and reduced postoperative length of stay (9 ± 8 vs 10 ± 7 days; P = 0.004). Blood transfusions (36.4% vs 30.8%; P ≤ 0.001) and atrial fibrillation (26.0% vs 21.5%, P ≤ 0.001) were higher in patients who had the mini-AVR. CONCLUSIONS: In a large multi-institutional recent cohort, minimal access approach aortic valve replacement is associated with reduced 30-day mortality rates and shorter postoperative lengths of stay compared to standard sternotomy. A prospective randomized trial is needed to overcome the possible biases of a retrospective study.
No takes yet. Share an insight, caveat, or question.
Paparella et al. (2019) conducted a cohort in Surgical aortic valve replacement (n=5,801). Minimal access aortic valve replacement (mini-AVR) vs. Conventional aortic valve replacement (full sternotomy) was evaluated on 30-day mortality (p=0.036). Minimal access aortic valve replacement was associated with lower 30-day mortality compared to standard sternotomy in a propensity-matched cohort.
Synapse has enriched 10 related papers. Consider them for comparative context: